insights_auto
Why is SNES up 8.21%?
Dive Deeperchevron_right
SNES:NASDAQ
SenesTech Inc
$0.70
arrow_upward
+8.21%(+0.053) 1D
$0.69
arrow_downward
-1.14% (-0.0080)bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNES...
Open
$0.65
High
$0.77
Low
$0.60
Mkt. cap
3.78M
Avg. vol.
2.07M
Volume
0.00
52-wk high
$4.04
52-wk low
$0.55
EPS
-$1.36
Beta
0.25
Shares outstanding
5.42M
No. of employees
24
Open
$0.65
High
$0.77
Low
$0.60
Mkt. cap
3.78M
Avg. vol.
2.07M
Volume
0.00
52-wk high
$4.04
52-wk low
$0.55
EPS
-$1.36
Beta
0.25
Shares outstanding
5.42M
No. of employees
24
News stories
From web sources and news partners
Investing.com India
·
5 hours ago
Glenbrook Capital Management director buys $706k SenesTech stock By Investing.com
Investing.com India
·
5 hours ago
Form 13D/A SenesTech For: 19 October By Investing.com
Stock Titan
·
9 hours ago
A 426,000-share buy is among three purchases by Glenbrook accounts in SenesTech (SNES).
Investing.com
·
12 hours ago
Glenbrook Capital takes 30% stake in SenesTech, pushes changes
Profile
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona. Wikipedia
About SenesTech Inc
CEOKen Siegel
Employees24
Founded2004
HeadquartersSurprise, Arizona, United States
SectorPharmaceutical industry
Websitesenestech.com